The Venture Codex Logo

The Venture Codex

Glenview Capital

767 Fifth Avenue, 44th Floor, New York, NY, 10153, United States

Overview

Hedge fund managing approximately $9.2 billion in capital.

Founded

2000

Deals · 12mo

0

Links

LinkedIn

Stage focus

Multi-stage

Geographic focus

United Kingdom
United States

Sector focus

—

Investment portfolio

4rounds
NAMEDATESIZE
Quanta
Nov 2024Led
$60 MSeries E
Limber
Oct 2022Participated
$11 MSeries A
Quanta
Jun 2021Led
$245 MSeries D
Tesseract Health
Apr 2021Participated
$80 MSeries B
Quanta
Nov 2024Led
$60 MSeries E
Limber
Oct 2022Participated
$11 MSeries A
Quanta
Jun 2021Led
$245 MSeries D
Tesseract Health
Apr 2021Participated
$80 MSeries B
4
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Glenview Capital: 4 funding rounds are recorded in the selected participation categories.All available history.
Glenview Capital: 4 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B01
Series C+20

Monthly Deal Activity

Glenview Capital: 4 deals are recorded across 67 months.All available history.
Glenview Capital: 4 deals are recorded across 67 months. All available history
MonthDeals
Apr '211
May '210
Jun '211
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '221
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '241
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Glenview Capital: Health & Life Sciences is the largest displayed sector by deal count (4 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Glenview Capital: Health & Life Sciences is the largest displayed sector by deal count (4 deals). All available history
SectorDeals
Health & Life Sciences4
Manufacturing2
Consumer & Lifestyle1

Deal Size Distribution

Glenview Capital: 4 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Glenview Capital: 4 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M2
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Glenview Capital: Europe has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Glenview Capital: Europe has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
Europe2
United States2
Glenview Capital: 17 co-investors are shown, with btov Partners sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Glenview Capital: 17 co-investors are shown, with btov Partners sharing 2 recorded deals. All available history
Co-investorShared deals
btov Partners2
Novo Holdings2
BlackRock1
BlueCross BlueShield Venture Partners1
Eldridge1
Foresite Capital1
Millennium Management1
Monashee Investment Management1
Opaleye Management1
Orlando Health Ventures1
Puhua Capital1
Sandbox1
Sands Capital1
Segulah Medical Acceleration1
Seroba Life Sciences1
The Grands1
Wellington Partners1

Investment Strategy

Glenview Capital: Led accounts for 50% and participating for 50% of round participation.All available history.
Glenview Capital: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led250%
Participating250%
Glenview Capital: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Glenview Capital: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led2100%

Team

Dennis Chao

Senior Analyst - Therapeutics

Jeffrey Patterson

Partner | Head of Trading

Larry Robbins

Founder and CEO

Lee Hathaway

Partner, Co-Head of Healthcare at Glenview Capital